Literature DB >> 2939201

Electrophoretic separation of myosin isoenzymes. Implications for the histochemical demonstration of fibre types in biopsy specimens of human skeletal muscle.

W T Perrie, S J Bumford.   

Abstract

Myosin, the protein responsible for ATPase activity and hence the conversion of chemical into mechanical energy by muscle, is known to exist in polymorphic forms. A correlation exists between the myosin type present in a muscle as demonstrated by gel electrophoresis and the staining of sections of that muscle for ATPase activity. It is still possible to determine the major fibre type in a muscle electrophoretically even when pathological changes make interpretation of histochemical staining of sections difficult. The refinement of the electrophoretic technique in the present study has separated myosin from some specimens of muscle into three isoenzyme forms. The density of staining of the three myosin bands corresponds to the numbers of muscle fibres staining dark, pale or intermediate grey for ATPase activity after preincubation at pH 4.6. As other workers have noted, some specimens of muscle show a continuum or wide range of intermediate staining fibres after preincubation at pH 4.6. However, this is not reflected in the electrophoretic patterns which show only the three isoenzyme forms of myosin rather than a large range of these molecules. A particular myosin molecule would appear to be specific for each of the histochemical fibre types 1, 2A and 2B.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2939201     DOI: 10.1016/0022-510x(86)90067-5

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  12 in total

1.  Validation of a simple, rapid, and economical technique for distinguishing type 1 and 2 fibres in fixed and frozen skeletal muscle.

Authors:  W M H Behan; D W Cossar; H A Madden; I C McKay
Journal:  J Clin Pathol       Date:  2002-05       Impact factor: 3.411

2.  Effect of aging on rat skeletal muscle beta-AR function in male Fischer 344 x brown Norway rats.

Authors:  L M Larkin; J B Halter; M A Supiano
Journal:  Am J Physiol       Date:  1996-02

3.  Fibre type-specific expression of p94, a skeletal muscle-specific calpain.

Authors:  S W Jones; T Parr; P L Sensky; G P Scothern; R G Bardsley; P J Buttery
Journal:  J Muscle Res Cell Motil       Date:  1999-05       Impact factor: 2.698

4.  Relationship between myosin heavy chain IId isoform and fibre types in soleus muscle of the rat after hindlimb suspension.

Authors:  Y Oishi
Journal:  Eur J Appl Physiol Occup Physiol       Date:  1993

5.  Heterogeneity of fast-oxidative muscle fibers of chicken demonstrated by anti-myosin monoclonal antibodies.

Authors:  Y Zhang; S G Lewis; S A Shafiq
Journal:  Histochemistry       Date:  1989

6.  Postmortem alterations in the pH range of myofibrillar ATPase activation/inactivation.

Authors:  Seth S Jump; Mark D Schuenke; Robert S Staron
Journal:  Histochem Cell Biol       Date:  2003-01-15       Impact factor: 4.304

7.  Correlation between percentage fiber type area and myosin heavy chain content in human skeletal muscle.

Authors:  A C Fry; C A Allemeier; R S Staron
Journal:  Eur J Appl Physiol Occup Physiol       Date:  1994

8.  Exercise training induces transitions of myosin isoform subunits within histochemically typed human muscle fibres.

Authors:  H Baumann; M Jäggi; F Soland; H Howald; M C Schaub
Journal:  Pflugers Arch       Date:  1987-08       Impact factor: 3.657

9.  Changes in fibre-type composition and myosin heavy-chain IId isoform in rat soleus muscle during recovery period after hindlimb suspension.

Authors:  Y Oishi; H Yamamoto; E Miyamoto
Journal:  Eur J Appl Physiol Occup Physiol       Date:  1994

10.  Influence of the contractile properties of muscle on motor unit firing rates during a moderate-intensity contraction in vivo.

Authors:  Michael A Trevino; Trent J Herda; Andrew C Fry; Philip M Gallagher; John P Vardiman; Eric M Mosier; Jonathan D Miller
Journal:  J Neurophysiol       Date:  2016-05-04       Impact factor: 2.714

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.